PURPOSE: Chest symptoms, along with standard cardiovascular risk factors, are commonly factored into pretest risk stratification of patients who are referred for stress testing. We sought to determine the independent prognostic value of chest symptoms. METHODS: We studied the outcomes of 10,870 patients referred for symptom-limited exercise testing who had no history of myocardial revascularization, heart failure, or arrhythmias. Chest symptoms were prospectively characterized according to prespecified definitions. Propensity analysis was used to account for differences in baseline and exercise characteristics. RESULTS: Typical angina was present in 635 patients (6%), atypical angina in 3408 (33%), nonanginal chest pain in 1805 (17%), and dyspnea in 841 (8%). The remaining 4181 patients (38%) were asymptomatic. During a mean follow-up of 4.3 years, there were 381 deaths. After propensity matching patients who had typical angina with asymptomatic patients, symptoms were not predictive of mortality (adjusted hazard ratio [HR] = 0.8; 95% confidence interval [CI]: 0.6 to 1.3; P = 0.4). Among patients who had chest pain, typical angina was associated with a highly significant risk of mortality as compared with nonanginal chest pain (HR = 2.7; 95% CI: 1.4 to 5.1; P = 0.002), but not compared with atypical angina (HR = 1.3; 95% CI: 0.9 to 2.1; P = 0.21). CONCLUSION: After accounting for baseline and exercise characteristics, the presence of symptoms was not independently associated with increased mortality among patients undergoing testing for known or suspected coronary disease. Among patients who actually had chest pain, typical angina carried a higher mortality risk. Copyright 2004 Elsevier Inc.
PURPOSE: Chest symptoms, along with standard cardiovascular risk factors, are commonly factored into pretest risk stratification of patients who are referred for stress testing. We sought to determine the independent prognostic value of chest symptoms. METHODS: We studied the outcomes of 10,870 patients referred for symptom-limited exercise testing who had no history of myocardial revascularization, heart failure, or arrhythmias. Chest symptoms were prospectively characterized according to prespecified definitions. Propensity analysis was used to account for differences in baseline and exercise characteristics. RESULTS: Typical angina was present in 635 patients (6%), atypical angina in 3408 (33%), nonanginal chest pain in 1805 (17%), and dyspnea in 841 (8%). The remaining 4181 patients (38%) were asymptomatic. During a mean follow-up of 4.3 years, there were 381 deaths. After propensity matching patients who had typical angina with asymptomatic patients, symptoms were not predictive of mortality (adjusted hazard ratio [HR] = 0.8; 95% confidence interval [CI]: 0.6 to 1.3; P = 0.4). Among patients who had chest pain, typical angina was associated with a highly significant risk of mortality as compared with nonanginal chest pain (HR = 2.7; 95% CI: 1.4 to 5.1; P = 0.002), but not compared with atypical angina (HR = 1.3; 95% CI: 0.9 to 2.1; P = 0.21). CONCLUSION: After accounting for baseline and exercise characteristics, the presence of symptoms was not independently associated with increased mortality among patients undergoing testing for known or suspected coronary disease. Among patients who actually had chest pain, typical angina carried a higher mortality risk. Copyright 2004 Elsevier Inc.
Authors: Rine Nakanishi; Heidi Gransar; Alan Rozanski; Jamal S Rana; Victor Y Cheng; Louise E J Thomson; Romalisa Miranda-Peats; Damini Dey; Sean W Hayes; John D Friedman; James K Min; Daniel S Berman Journal: Int J Cardiovasc Imaging Date: 2016-02 Impact factor: 2.357
Authors: Alan Rozanski; Heidi Gransar; Nathan D Wong; Leslee J Shaw; Romalisa Miranda-Peats; Sean W Hayes; John D Friedman; Daniel S Berman Journal: J Nucl Cardiol Date: 2007 Sep-Oct Impact factor: 5.952
Authors: F Cademartiri; E Maffei; A Palumbo; R Malagò; F Alberghina; A Aldrovandi; V Brambilla; G Runza; L La Grutta; A Menozzi; L Vignali; G Casolo; M Midiri; N R Mollet Journal: Radiol Med Date: 2007-10-21 Impact factor: 3.469
Authors: Alexander R van Rosendael; A Maxim Bax; Inge J van den Hoogen; Jeff M Smit; Subhi J Al'Aref; Stephan Achenbach; Mouaz H Al-Mallah; Daniele Andreini; Daniel S Berman; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin DeLago; Gudrun Feuchtner; Martin Hadamitzky; Joerg Hausleiter; Philipp A Kaufmann; Yong-Jin Kim; Jonathon A Leipsic; Erica Maffei; Hugo Marques; Pedro de Araújo Gonçalves; Gianluca Pontone; Gilbert L Raff; Ronen Rubinshtein; Todd C Villines; Heidi Gransar; Yao Lu; Jessica M Peña; Fay Y Lin; Leslee J Shaw; Jagat Narula; James K Min; Jeroen J Bax Journal: Eur Heart J Cardiovasc Imaging Date: 2022-01-24 Impact factor: 6.875
Authors: Alan Rozanski; Heidi Gransar; Leslee Shaw; Nathan D Wong; James Min; Romalisa Miranda-Peats; Sean W Hayes; John D Friedman; Daniel S Berman Journal: J Nucl Cardiol Date: 2010-12-24 Impact factor: 5.952
Authors: Rajiv Paudel; Natalia Beridze; Wilbert S Aronow; Chul Ahn; Abdallah Sanaani; Pallak Agarwal; Kim Farell; Diwakar Jain; Robert Timmermans; Howard A Cooper; Julio A Panza Journal: Arch Med Sci Date: 2016-07-01 Impact factor: 3.318